Cumulative meta-analysis of epidermal growth factor receptor-tyrosine kinase inhibitors as first-line therapy in metastatic non-small-cell lung cancer

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000268 ◽

2015 ◽

Vol 26 (9) ◽

pp. 995-1003 ◽

Author(s):

Sávia R.C. Normando ◽

Felipe M. Cruz ◽

Auro del Giglio

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

First Line Therapy ◽

Line Therapy ◽

Epidermal Growth

Download Full-text

Cost-effectiveness analysis of tyrosine kinase inhibitors (erlotinib, gefitinib, afatinib and osimertinib) as first-line therapy for epidermal growth factor receptor-mutated advanced non-small cell lung cancer

Journal of Chinese Pharmaceutical Sciences ◽

10.5246/jcps.2021.03.021 ◽

2021 ◽

Vol 30 (3) ◽

pp. 253-263

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

First Line Therapy ◽

Effectiveness Analysis ◽

Line Therapy ◽

Epidermal Growth

Download Full-text

Comparison of the effects of the three major tyrosine kinase inhibitors as first-line therapy for non-small-cell lung cancer harboring epidermal growth factor receptor mutations

10.18632/oncotarget.24386 ◽

2018 ◽

Vol 9 (36) ◽

pp. 24237-24247 ◽

Author(s):

Chih-Yen Tu ◽

Chuan-Mu Chen ◽

Wei-Chih Liao ◽

Biing-Ru Wu ◽

Chih-Yu Chen ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

First Line Therapy ◽

Line Therapy ◽

Epidermal Growth

Download Full-text

Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non‐small cell lung cancer patients: A meta‐analysis

Thoracic Cancer ◽

10.1111/1759-7714.13878 ◽

2021 ◽

Author(s):

Nobuaki Kobayashi ◽

Seigo Katakura ◽

Chisato Kamimaki ◽

Kohei Somekawa ◽

Nobuhiko Fukuda ◽

...

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Resistance Mechanisms ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Comparison Between Second- and Third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as First-line Treatment in Patients With Non-small-cell Lung Cancer: A Retrospective Analysis

Anticancer Research ◽

10.21873/anticanres.15331 ◽

2021 ◽

Vol 41 (10) ◽

pp. 5137-5145

Author(s):

SHO MITSUYA ◽

KENJIRO TSURUOKA ◽

KIYOE KANAOKA ◽

TOMOYA FUNAMOTO ◽

HIROYUKI TSUJI ◽

...

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Third Generation ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Tyrosine Kinase Inhibitors ◽

First Line Treatment

Download Full-text

Management of patients with epidermal growth factor receptor mutation-positive (EGFRm+) non-small cell lung cancer (NSCLC) after radiological progression to first-line therapy with gefitinib.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e19124 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e19124-e19124

Author(s):

Yukio Hosomi ◽

Chiharu Tanai ◽

Kiyotaka Yoh ◽

Yasushi Goto ◽

Yasuo Ohashi ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Radiological Progression ◽

First Line Therapy ◽

Line Therapy ◽

Epidermal Growth

Download Full-text

Is There a Survival Benefit of First-Line Epidermal Growth Factor Receptor Tyrosine-Kinase Inhibitor Monotherapy Versus Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?: A Meta-Analysis

Targeted Oncology ◽

10.1007/s11523-015-0373-x ◽

2015 ◽

Vol 11 (1) ◽

pp. 41-47 ◽

Author(s):

Gaetan Des Guetz ◽

Thierry Landre ◽

Bernard Uzzan ◽

Kader Chouahnia ◽

Patrick Nicolas ◽

...

Keyword(s):

Lung Cancer ◽

Receptor Tyrosine Kinase ◽

Survival Benefit ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth

Download Full-text

Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis

Lung Cancer ◽

10.1016/j.lungcan.2008.12.011 ◽

2009 ◽

Vol 65 (3) ◽

pp. 351-354 ◽

Author(s):

Jeong-Eun Kim ◽

Dae Ho Lee ◽

Yunsuk Choi ◽

Dok Hyun Yoon ◽

Sang-We Kim ◽

...

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Adenocarcinoma Of The Lung ◽

First Line Therapy ◽

Line Therapy ◽

Epidermal Growth ◽

Never Smokers ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Gefitinib with pemetrexed as first-line therapy in patients with advanced nonsquamous non-small cell lung cancer with activating epidermal growth factor receptor mutations

Annals of Translational Medicine ◽

10.21037/atm.2016.12.64 ◽

2017 ◽

Vol 5 (1) ◽

pp. 11-11

Author(s):

Shinkyo Yoon ◽

Dae Ho Lee ◽

Sang-We Kim

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

First Line Therapy ◽

Line Therapy ◽

Epidermal Growth

Download Full-text

A Meta-Analysis of Randomized Clinical Trials (RCTS) on Epidermal Growth Factor Receptor -Tyrosine Kinase Inhibitors (EGFR-TKIS) for Advanced Non-Small Cell Lung Cancer (NSCLC)

Value in Health ◽

10.1016/j.jval.2014.03.397 ◽

2014 ◽

Vol 17 (3) ◽

pp. A68

Author(s):

T. Zhang ◽

J. Xu ◽

J. Ma ◽

S. Cai ◽

C. Wu ◽

...

Keyword(s):

Receptor Tyrosine Kinase ◽

Randomized Clinical Trials ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tkis ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

RETRACTED ARTICLE: The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Molecularly Selected Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of 30 Randomized Controlled Trials

Targeted Oncology ◽

10.1007/s11523-015-0376-7 ◽

2015 ◽

Vol 11 (1) ◽

pp. 49-58 ◽

Author(s):

Jin Liu ◽

Zhixin Sheng ◽

Yanxia Zhang ◽

Guixin Li

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Randomized Controlled ◽

Retracted Article ◽

Epidermal Growth ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text